| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010912 Use of Alkaline Phosphatase for the Detoxification of Lps Present at Mucosal Barriers |
| 01/08/2009 | US20090010911 Methods and compositions for affecting cyclophilin a regulation of kinases in modulating cellular activities |
| 01/08/2009 | US20090010897 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 01/08/2009 | US20090010876 Visfatin and uses thereof |
| 01/08/2009 | DE102007051090A1 Use of a serotonergic compound as a neuroprotective agent for treating focal cerebral ischemia after the development of an acute phase ischemia, for the neuro-regeneration during the treatment of neuronal disease and to treat e.g. stroke |
| 01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | CA2695031A1 Novel substituted piperidones as hsp inducers |
| 01/08/2009 | CA2694253A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2692502A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | CA2692268A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2691746A1 Use of alpha-ketoglutarate in the treatment of hypertension |
| 01/08/2009 | CA2691662A1 Imidazole derivatives as ccr2 receptor antagonists |
| 01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011501A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2011497A1 Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity |
| 01/07/2009 | EP2011489A2 Method to inhibit ischemia and reperfusion injury |
| 01/07/2009 | EP2010921A2 Method for diagnosing cardiovascular diseases |
| 01/07/2009 | EP2010535A1 Thioxanthine derivatives and their use as inhibitors of mpo |
| 01/07/2009 | EP2010534A1 Thioxanthine derivatives and their use as inhibitors of mpo |
| 01/07/2009 | EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP2010176A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 01/07/2009 | EP2010173A1 Compounds for treating pulmonary hypertension |
| 01/07/2009 | EP2009992A2 Il-8 receptor antagonists |
| 01/07/2009 | EP1858867B1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 01/07/2009 | EP1501531B1 Method for treating anxiety in older subjects |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1425277B1 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1242103B1 Extracts derived from pueraria mirifica and extraction thereof |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | CN101338306A Method for treating cell proliferation hyperthyroidism based on anti-SURVIVIN ribozyme |
| 01/07/2009 | CN101337984A Bearberry type pentacyclic triterpenes amino acid derivates, method for preparing same and pharmaceutical use thereof |
| 01/07/2009 | CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337932A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337931A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337891A Nitric oxide donor type 3-butylphthalide derivates, method for preparing same and pharmaceutical use |
| 01/07/2009 | CN101337063A Drop pills for treating cardiac infarction |
| 01/07/2009 | CN101337050A Traditional Chinese medicine composition for treating the cerebrovascular accident and preparation method thereof |
| 01/07/2009 | CN101337038A Xinnao Maitong pill |
| 01/07/2009 | CN101337032A Traditional Chinese medicine for treating apoplexy and production method thereof |
| 01/07/2009 | CN101337022A Oral preparation capable of reducing blood fat and blood pressure, nourishing the heart and protecting brain and preparation method thereof |
| 01/07/2009 | CN101337017A Medicine for treating coronary disease |
| 01/07/2009 | CN101337001A Solanum xanthocarpum extract, preparation method and use thereof |
| 01/07/2009 | CN101337000A Solanum nigrum extract, preparation method and use thereof |
| 01/07/2009 | CN101336981A Medicine for treating hemiparalysis |
| 01/07/2009 | CN101336980A Medicine for treating cardiac and cerebral vascular disease |
| 01/07/2009 | CN101336961A Coronary heart disease drop pill and preparation method thereof |
| 01/07/2009 | CN101336936A Compound thrombolytic and pericardium clearing complex capsule and preparation method thereof |
| 01/07/2009 | CN101336927A Use of morroniside in preventing or treating brain fundamental sickness |
| 01/07/2009 | CN101336922A Rosuvastatin amlodipine composition |
| 01/07/2009 | CN101336921A Rosuvastatin azelnidipine composition |
| 01/07/2009 | CN101336920A Stable medicine combination |
| 01/07/2009 | CN101336902A Liposomes sodium morrhuate |
| 01/07/2009 | CN101336886A Soluble preparation of breviscapine |
| 01/07/2009 | CN101336705A Health food and its preparation method |
| 01/07/2009 | CN100448885C Dwarf lilyturf polysaccharide MDG-1 sulfated derivative, its preparation method and uses |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/07/2009 | CN100448852C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 01/07/2009 | CN100448847C Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
| 01/07/2009 | CN100448474C Mongolian medicine compound preparation for curing cardiac disease |
| 01/07/2009 | CN100448471C Medicine for curing cardiovascular disease and its preparation method |
| 01/07/2009 | CN100448457C Effective position of pilose asiabell root, preparation, medication use and preparation method |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/07/2009 | CN100448442C Use of elastic protease inhibitor for preparing medicine for protecting cerebral hemorrhage |
| 01/07/2009 | CN100448432C Method for preparing nimodipine dispersible tablet with high dissolution |
| 01/07/2009 | CN100448430C Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process |
| 01/07/2009 | CN100448384C Blood pressure lowering pillow |
| 01/07/2009 | CN100448360C Kudzu vine and leaf tea |
| 01/07/2009 | CN100448358C Oil/fat composition |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 01/06/2009 | CA2244512C Dietary supplements containing natural ingredients |
| 01/06/2009 | CA2177007C Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/06/2009 | CA2169219C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them |